News
-
-
-
-
-
-
-
-
PRESS RELEASE
AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT
AATec Medical reports significant progress in unlocking therapeutic potential of AAT for treating inflammatory lung diseases in its first year. Company advances lead candidate ATL-105 for NCFB -
-
PRESS RELEASE
AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
AATec Medical appoints Prof. Dr. Claus Franz Vogelmeier, a renowned pulmonology expert, to its Scientific Advisory Board, enhancing expertise in inflammatory lung diseases. Visit www.aatec-medical.com for details